Dysregulation of the transforming growth factor beta (TGF-β) pathway plays a central role in inflammation, fibrogenesis, and immunomodulation in the HCC microenvironment [48, 49]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.